Steven Prestrelski
Chief Scientific Officer, XERIS PHARMACEUTICALS INC.
Companies
- Xeris Biopharma Holdings, Inc.Chief Scientific Officer Oct 5, 2021 to Feb 1, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Xeris Biopharma Holdings, Inc. XERS719,780 shares2$7.9M at $11.04Jan 31, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 31, 2023Granted 150,000 shares of Xeris Biopharma Holdings, Inc.2
- Feb 22, 2022Sold 11,228 shares at $2.42 of Xeris Biopharma Holdings, Inc.3
- Feb 22, 2022Exercised options 11,228 shares at $0.69 of Xeris Biopharma Holdings, Inc.3
- Jan 3, 2022Granted 75,000 shares of Xeris Biopharma Holdings, Inc.4
- Oct 5, 2021Returned to company 110,000 shares of CIK 13463025
- Oct 5, 2021Granted 110,000 shares of Xeris Biopharma Holdings, Inc.6
- Oct 5, 2021Returned to company 384,780 shares of CIK 13463025
- Oct 5, 2021Granted 384,780 shares of Xeris Biopharma Holdings, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 24, 2022
- 4SEC EDGARForm 4 filed Jan 5, 2022
- 5SEC EDGARForm 4 filed Oct 5, 2021
- 6SEC EDGARForm 4 filed Oct 5, 2021